Bluerock Therapeutics
Clinical trials sponsored by Bluerock Therapeutics, explained in plain language.
-
Brain cell transplant trial offers new hope for Parkinson's patients
Disease control Recruiting nowThis study tests a treatment called bemdaneprocel, which uses special brain cells to replace those lost in Parkinson's disease. About 102 adults with Parkinson's will receive either the cell therapy or a sham surgery. The goal is to see if it increases good movement time without …
Phase: PHASE3 • Sponsor: BlueRock Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Experimental cell therapy aims to restore sight in rare eye diseases
Disease control Recruiting nowThis study tests OpCT-001, a therapy made from special cells that may replace damaged light-sensing cells in the eye. It is for adults with inherited eye diseases like retinitis pigmentosa and Usher syndrome. The goal is to check safety and see if it can improve vision. About 54 …
Phase: PHASE1, PHASE2 • Sponsor: BlueRock Therapeutics • Aim: Disease control
Last updated May 07, 2026 18:39 UTC